Codamin -P (codeine + paracetamol): Uses, Dosage & Side Effects

What it's for (Indications)

Codeine combined with paracetamol is indicated for the symptomatic relief of mild to moderate pain, particularly when paracetamol alone is not sufficient to alleviate the pain.
This combination analgesic is effective across a range of painful conditions.
Common indications include, but are not limited to, headaches (including tension headaches and migraines), dental pain (e.
g.
, toothache post-extraction), musculoskeletal pain (such as backache, muscle aches, sprains, and strains), neuropathic pain (e.
g.
, neuralgia), dysmenorrhoea (period pain), and the symptomatic relief of pain associated with colds, influenza, and other viral infections.
The inclusion of codeine, a weak opioid, enhances the analgesic effect compared to paracetamol alone, making it suitable for pain that impacts daily activities but does not necessitate a stronger opioid intervention.
It is important to note that due to the opioid component, this combination should be used for the shortest possible duration at the lowest effective dose.

Dosage Information

Type	Guideline
Standard	Prescribe only by healthcare professionals knowledgeable about opioid use and risk mitigation. Use the lowest effective dosage for the shortest duration consistent with individual patient goals. Reserve titration to higher doses for patients where lower doses are insufficiently effective and benefits clearly outweigh substantial risks, as overdose risk increases with higher opioid doses. Many acute pain conditions may require only a few days of opioid analgesic.

Type

Guideline

Standard

Prescribe only by healthcare professionals knowledgeable about opioid use and risk mitigation. Use the lowest effective dosage for the shortest duration consistent with individual patient goals. Reserve titration to higher doses for patients where lower doses are insufficiently effective and benefits clearly outweigh substantial risks, as overdose risk increases with higher opioid doses. Many acute pain conditions may require only a few days of opioid analgesic.

Safety & Warnings

Common Side Effects

As with all medications, the codeine + paracetamol combination can cause side effects, although not everyone experiences them.
The most common side effects are typically associated with the codeine component due to its opioid nature.
These include gastrointestinal disturbances such as constipation, nausea, and vomiting, as well as CNS effects like dizziness, drowsiness, sedation, and headache.
Dry mouth and sweating are also frequently reported.
Less common but potentially more serious side effects of codeine can include respiratory depression (especially at higher doses or in susceptible individuals), allergic reactions (rash, itching, urticaria), urinary retention, and rarely, paradoxical excitation.
Prolonged use can lead to tolerance, physical dependence, and addiction.
Paracetamol, at therapeutic doses, is generally well-tolerated.
However, rare side effects can include hypersensitivity reactions (e.
g.
, skin rash, angioedema) and blood dyscrasias (e.
g.
, thrombocytopenia, leukopenia).
The most significant and life-threatening adverse effect of paracetamol is hepatotoxicity, which occurs following acute overdose due to the accumulation of a toxic metabolite (N-acetyl-p-benzoquinone imine, NAPQI) that depletes hepatic glutathione stores.
Chronic high doses can also lead to nephrotoxicity.
Patients should be advised to adhere strictly to recommended dosages to minimize the risk of adverse events.

Serious Warnings

Black Box Warning: WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF ACETAMINOPHEN AND CODEINE PHOSPHATE TABLETS. Addiction, Abuse and Misuse: The use of acetaminophen and codeine phosphate tablets exposes patients and other users to the risks of opioid addiction, abuse and misuse, which can lead to overdose and death. Assess each patient’s risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions. Life-Threatening Respiratory Depression.
This medication carries a risk of opioid addiction, abuse, and misuse, which can lead to overdose and death; patients' risk should be assessed regularly.
There is a risk of life-threatening respiratory depression.
Patients should consult their doctor before use if pregnant or lactating.
Avoid driving or operating machinery as it may impair ability.
Alcohol consumption should be avoided.
Use with extreme caution in patients with hypothyroidism, renal impairment (kidney disorder), and hepatic impairment (liver disorder).
Should be prescribed by healthcare professionals knowledgeable about opioid use and risk mitigation.
Use the lowest effective dose for the shortest duration.
Titration to higher doses should be reserved for cases where lower doses are ineffective and benefits clearly outweigh substantial risks.
Many acute pain conditions require only short-term opioid use.
Not for use in children younger than 12 years of age.
Contraindicated for post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy.

How it Works (Mechanism of Action)

The therapeutic effect of this combination medicine is derived from the distinct yet complementary mechanisms of its two active components. Paracetamol (acetaminophen) is primarily thought to exert its analgesic and antipyretic effects by inhibiting prostaglandin synthesis, predominantly within the central nervous system (CNS). While its exact mechanism is not fully elucidated, it is believed to involve selective inhibition of cyclooxygenase enzymes (COX-1 and COX-2) in the brain, thereby reducing the formation of prostaglandins responsible for pain and fever. It may also involve the activation of descending serotonergic pathways, contributing to its analgesic action. Codeine, on the other hand, is a weak opioid analgesic classified as a prodrug. It exerts its effects after being metabolized into its active metabolite, morphine, primarily via the cytochrome P450 2D6 (CYP2D6) enzyme in the liver. Morphine acts as an agonist at mu-opioid receptors located throughout the CNS, spinal cord, and peripheral tissues. This interaction leads to a cascade of effects, including inhibition of ascending pain pathways, altered perception of and emotional response to pain, and a reduction in the release of nociceptive neurotransmitters. The combined action of these two agents provides a more potent analgesic effect than either drug administered individually.